PATENT CLAIM ANALYSIS

Application Number: 15940158
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["435", "007100"]

Abstract:
Certain embodiments are directed to marker peptides or marker peptide antibodies can be used in producing diagnostic kits or used in diagnostic methods for Alzheimer's disease. The antibodies and/or marker peptides can be used in immunohistochemical and biochemical methods for qualitative and quantitative analysis of marker peptide levels and/or localization in brain samples and CSF samples.

Claim (Index 9):
A diagnostic kit for Alzheimer's disease comprising (a) an isolated APP Alzheimer's disease marker peptide between the 10 kDa and 15 kDa having an amino acid sequence consisting of 90 to 133 contiguous amino acids of SEQ ID NO:2, and (b) an antibody that binds APP Alzheimer's disease marker peptide between the 10 kDa and 15 kDa.

Metadata:
- Claim Count in Document: 15.0
- Percentile: 90.0
- Lexical Diversity: 1.59459
- Patent Class: 435.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['09980881', '14810760', '15342629', '13582308', '15207836']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.5949615489456214
- 35 USC 102 Novelty (BERT): 0.5232105270725832
- Combined Prediction Score: 0.5877864467583175
- Mean Citation Score: 332.7754740000001
- Max Citation Score: 346.69672
- Similarity Product: 254.5053657686377

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test